Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328094 · ClinicalTrials.gov registry record · NA
Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT00328094 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 242 participants.
The verdict
NCT00328094, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
Aggressive intraoperative and postoperative management of blood glucose may substantially decrease perioperative cardiovascular and infectious complications in diabetic and non-diabetic patients undergoing vascular surgery. The purpose of this study is to compare the tight versus traditional blood glucose control in diabetics and non-diabetics undergoing vascular surgery in regard to their postoperative fatal and nonfatal cardiac outcomes, and the secondary effects such as rate of infections, overall morbidity and 30-day mortality.
Interventions
- DRUG continuous intravenous insulin infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328094
The ClinicalTrials.gov registry entry for NCT00328094 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which continuous intravenous insulin infusion is the first listed.
NCT00328094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00328094 about?
NCT00328094 is a clinical study titled "Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery". Aggressive intraoperative and postoperative management of blood glucose may substantially decrease perioperative cardiovascular and infectious complications in diabetic and non-diabetic patients undergoing vascular surgery. The purpose of this study is to compare the tight versus traditional blood ...
What is the current status of trial NCT00328094?
This trial is currently terminated. It is a NA study. The enrollment target is 242 participants. The study started on 2006-03. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00328094?
The interventions under investigation include: continuous intravenous insulin infusion (DRUG).
Who is sponsoring clinical trial NCT00328094?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.